1.
Arq Bras Cardiol
; 59(2): 113-7, 1992 Aug.
Artigo
em Português
| MEDLINE
| ID: mdl-1341156
RESUMO
PURPOSE: To comprove the efficiency of acetyl salicylic acid (ASA) as platelet antiaggregant drug, a 100 mg/day dose base. METHODS: Two hundred and fifty-eight patients were studied between 1988 and 1990. Platelet functions were measured using an aggregometer plus ADP 5 as platelet aggregation inductor. RESULTS: Two groups were studied: 1st group, using ASA (111 patients), 91 hypoaggregants; 2nd group, not using ASA (147 patients), 120 normals, 12 hypoaggregants and 15 hyperaggregants. From the 2nd group, 91 had another evaluation under the use of ASA and showed a clear effect of the drug. CONCLUSION: The use of aspirin, 100 mg/day dose, is enough to reduce platelet antiaggregation.
Assuntos
Aspirina/administração & dosagem , Adolescente , Adulto , Idoso , Criança , Avaliação de Medicamentos , Cardiopatias/sangue , Cardiopatias/tratamento farmacológico , Hemostasia/efeitos dos fármacos , Humanos , Hipertensão/sangue , Hipertensão/tratamento farmacológico , Pessoa de Meia-Idade , Agregação Plaquetária/efeitos dos fármacos
2.
Lancet
; 2(7995): 1139-40, 1976 Nov 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-62977
3.
Hospital (Rio J)
; 77(6): 1847-62, 1970 Jun.
Artigo
em Português
| MEDLINE
| ID: mdl-4922278